dactinomycin has been researched along with gallic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dairi, T; Hoang, NN; Ki, DW; Kodama, T; Lae, KZW; Lee, YE; Morita, H; Ngwe, H; Win, NN; Wong, CP | 1 |
| Higashio, K; Itagaki, Y; Kawanishi, G; Mitsuda, S; Shima, N; Suzuki, A | 1 |
| Habtemariam, S | 1 |
| Anand-Srivastava, MB; Li, Y | 1 |
4 other study(ies) available for dactinomycin and gallic acid
| Article | Year |
|---|---|
Flavonoids from Woodfordia fruticosa as potential SmltD inhibitors in the alternative biosynthetic pathway of peptidoglycan.
Topics: DNA Ligase ATP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Molecular Structure; Peptidoglycan; Stenotrophomonas maltophilia; Structure-Activity Relationship; Woodfordia | 2021 |
Role of Ca2+ in t-PA production by human embryonic lung diploid fibroblast, IMR-90 cells, stimulated by proteose peptone.
Topics: Binding, Competitive; Calcimycin; Calcium; Caseins; Cell Line; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Egtazic Acid; Gallic Acid; Humans; Peptide Fragments; Peptones; Sulfonamides; Tissue Plasminogen Activator; Verapamil | 1991 |
Hamamelitannin from Hamamelis virginiana inhibits the tumour necrosis factor-alpha (TNF)-induced endothelial cell death in vitro.
Topics: Apoptosis; Cell Adhesion; Cell Line; Cell Survival; Dactinomycin; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Interactions; Endothelium; Enzyme-Linked Immunosorbent Assay; Free Radical Scavengers; Gallic Acid; Hamamelis; Hexoses; Humans; Intercellular Adhesion Molecule-1; Plant Extracts; Tumor Necrosis Factor-alpha; Up-Regulation | 2002 |
Implication of multiple signaling pathways in the regulation of angiotensin II induced enhanced expression of Giα proteins in vascular smooth muscle cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Bucladesine; Calcium; Cell Line; Chelating Agents; Dactinomycin; Drug Interactions; Egtazic Acid; Estrenes; Gallic Acid; Gene Expression Regulation; Genistein; GTP-Binding Protein alpha Subunits, Gi-Go; Imidazoles; Losartan; Nucleic Acid Synthesis Inhibitors; Protein Kinase Inhibitors; Pyridines; Pyrrolidinones; Rats; Signal Transduction; Type C Phospholipases | 2012 |